Baluch Khoso

Average Profitability
19.58%
Insider Buys Quantity
11
Insider Buys Sum
$211,097.27
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Baluch Khoso

According to the SEC Form 4 filings, Baluch Khoso, being in a position of

  1. director at Longeveron Inc.,
    оver the last 12 months, has bought 10000 shares for $14,257, and sold 0 shares,
    over all time since 2023-12-28, has bought 10000 shares for $14,257, and sold 0 shares.

The largest purchase of all time was on 2017-12-12 and amounted to 104166 shares of CorMedix Inc. for $50,000.

Biography of Baluch Khoso

No biography is available at this moment.

2023-12-29PurchaseLongeveron Inc.
LGVN
director
8,322
0.0349%
$1.43$11,915-81.36%
2023-12-28PurchaseLongeveron Inc.
LGVN
director
1,678
0.0068%
$1.40$2,342-81.65%
2020-08-13PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
4,830
0.0162%
$4.14$19,985+78.66%
2020-03-18PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
3,500
0.0149%
$2.61$9,135+146.38%
2019-03-26PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
2,500
0.0107%
$7.55$18,875-15.66%
2018-11-27PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
21,500
0.0243%
$1.21$26,015+33.25%
2018-11-26PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
3,500
0.0039%
$1.28$4,480+23%
2017-12-12PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
104,166
0.1531%
$0.48$50,000-22.03%
2017-08-18PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
36,207
0.0593%
$0.41$15,026+4.76%
2017-05-17PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
75,000
0.1462%
$0.47$35,625-4.35%
2016-12-09PurchaseCorMedix Inc.
CRMD
Chief Executive Officer
10,000
0.0268%
$1.77$17,700-67.82%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.